Vertex Pharmaceuticals (NQ: VRTX )

216.97 USD -0.93 (-0.43%)

Official Closing Price Updated: 7:37 PM EDT, Apr 26, 2021 Add to My Watchlist

Price and Volume

Volume	1,303,400
Open	217.74
Bid (Size)	216.06 (1)
Ask (Size)	219.00 (1)
Prev. Close	217.90
Today's Range	214.46 - 218.28
52wk Range	202.57 - 306.08
Shares Outstanding	259,960,062
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Vertex and CRISPR Therapeutics Announce Priority Medicines (PRIME) Designation Granted by the European Medicines Agency to CTX001™ for Transfusion-Dependent Beta Thalassemia

April 26, 2021

Vertex Pharmaceuticals and CRISPR Therapeutics Amend Collaboration for Development, Manufacturing and Commercialization of CTX001™ in Sickle Cell Disease and Beta Thalassemia

April 20, 2021

Performance

YTD	-5.43%	-5.43%
1 Month	+0.12%	+0.12%
3 Month	-10.09%	-10.09%
6 Month	+4.74%	+4.74%
1 Year	-19.19%	-19.19%

More News

Vertex and Obsidian Therapeutics Establish Collaboration to Discover Novel Therapies That Regulate Gene Editing

April 22, 2021

Top Stocks To Watch This Week? 4 Biotech Stocks To Know

April 20, 2021

Noteworthy ETF Outflows: IBB, ILMN, VRTX, REGN

April 26, 2021

Skyworks Lifts Nasdaq Ahead of Earnings; CRISPR Keeps Moving Forward

April 26, 2021

Notable Friday Option Activity: VRTX, CECE, CROX

April 23, 2021

Vertex to Announce First-Quarter 2021 Financial Results on April 29

April 19, 2021

Eaton Moves Up In Market Cap Rank, Passing Vertex Pharmaceuticals

April 22, 2021

3 Top Biotech Picks to Buy and Hold for the Next 10 Years

April 25, 2021

Vertex Pharma Inks Research, Licensing Agreement With Obsidian Therapeutics For Controllable Genetic Therapies

April 22, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.